Table 2.
Clinicopathologic parameter | PTP1B- positive | PTP1B- negative | Spearman's ρ | p value |
---|---|---|---|---|
Mean tumor size (mm) | 30.6 | 30.7 | 0.019 | 0.4797 |
Mean age at diagnosis (years) | 63.1 | 63.8 | –0.029 | 0.3159 |
n (%) | n (%) | Spearman's ρ | p value | |
---|---|---|---|---|
Tumor stage | 0.017 | 0.6283 | ||
pT1 | 178 (46.2) | 207 (53.7) | ||
pT2 | 371 (50.3) | 367 (49.7) | ||
pT3 | 52 (48.6) | 55 (51.4) | ||
pT4 | 82 (47.7) | 90 (52.3) | ||
Tumor grade | –0.018 | 0.4753 | ||
1 | 157 (48.5) | 167 (51.5) | ||
2 | 291 (50.5) | 285 (49.5) | ||
3 | 235 (46.8) | 267 (53.2) | ||
Lymph node stage | –0.026 | 0.6210 | ||
pN0 | 363 (50.1) | 362 (49.9) | ||
pN1 | 257 (47.6) | 283 (52.4) | ||
pN2 | 63 (47.0) | 71 (52.9) | ||
Estrogen receptor | –0.066 | 0.0137 | ||
ER+ | 527 (50.7) | 513 (49.3) | ||
ER– | 153 (43.1) | 202 (56.9) | ||
HER2 | –0.044 | 0.0985 | ||
HER2+ | 142 (53.1) | 125 (46.8) | ||
HER2– | 537 (47.5) | 592 (52.4) |